S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

InMode (INMD) Stock Forecast, Price & News

-0.42 (-1.77%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.23 million shs
Average Volume
2.81 million shs
Market Capitalization
$1.94 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive INMD News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

InMode logo

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.


See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$357.57 million
Cash Flow
$1.95 per share
Book Value
$4.85 per share


Net Income
$164.97 million
Pretax Margin




Free Float
Market Cap
$1.94 billion
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

1.87 out of 5 stars

Medical Sector

725th out of 1,416 stocks

Electromedical Equipment Industry

13th out of 29 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

InMode (NASDAQ:INMD) Frequently Asked Questions

Is InMode a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" InMode stock.
View analyst ratings for InMode
or view top-rated stocks.

When is InMode's next earnings date?

InMode is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for InMode

How were InMode's earnings last quarter?

InMode Ltd. (NASDAQ:INMD) issued its earnings results on Monday, May, 2nd. The healthcare company reported $0.36 earnings per share (EPS) for the quarter. The healthcare company had revenue of $85.90 million for the quarter, compared to the consensus estimate of $83.45 million. InMode had a net margin of 44.79% and a trailing twelve-month return on equity of 43.98%. The company's quarterly revenue was up 31.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.69 EPS.
View InMode's earnings history

When did InMode's stock split? How did InMode's stock split work?

Shares of InMode split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were issued to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of InMode stock prior to the split would have 200 shares after the split.

What guidance has InMode issued on next quarter's earnings?

InMode issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $2.06-$2.11 for the period, compared to the consensus EPS estimate of $2.09. The company issued revenue guidance of $415.00 million-$425.00 million, compared to the consensus revenue estimate of $423.28 million.

What price target have analysts set for INMD?

4 brokers have issued twelve-month target prices for InMode's shares. Their forecasts range from $50.00 to $85.00. On average, they expect InMode's share price to reach $68.50 in the next year. This suggests a possible upside of 193.4% from the stock's current price.
View analysts' price targets for InMode
or view top-rated stocks among Wall Street analysts.

Who are InMode's key executives?
InMode's management team includes the following people:
  • Mr. Yair Malca, Chief Financial Officer (Age 44, Pay $525k)
  • Mr. Alon Yaari, VP of Operations
  • Ms. Nava Tal-Launer, Chief Information Officer
  • Mr. Shakil Lakhani, Pres of North America (Age 39, Pay $2.67M)
  • Dr. Spero Theodorou M.D., Chief Medical Officer (Age 50, Pay $1.84M)
  • Mr. Moshe Mizrahy, Chairman & CEO (Age 69)
  • Dr. Michael Kreindel, CTO & Director (Age 54)
What is Moshe Mizrahy's approval rating as InMode's CEO?

1 employees have rated InMode CEO Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among InMode's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of InMode own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Square (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL).

When did InMode IPO?

(INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity served as the underwriters for the IPO and Baird was co-manager.

What is InMode's stock symbol?

InMode trades on the NASDAQ under the ticker symbol "INMD."

Who are InMode's major shareholders?

InMode's stock is owned by many different institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (3.82%), Acadian Asset Management LLC (3.62%), BlackRock Inc. (2.56%), William Blair Investment Management LLC (2.31%), Meitav Dash Investments Ltd. (1.19%) and State Street Corp (1.04%).

Which major investors are selling InMode stock?

INMD stock was sold by a variety of institutional investors in the last quarter, including Menora Mivtachim Holdings LTD., American Century Companies Inc., Spire Wealth Management, Jane Street Group LLC, Victory Capital Management Inc., Baltimore Washington Financial Advisors Inc., Meritage Portfolio Management, and Acadian Asset Management LLC.

Which major investors are buying InMode stock?

INMD stock was purchased by a variety of institutional investors in the last quarter, including Meitav Dash Investments Ltd., Renaissance Technologies LLC, Healthcare of Ontario Pension Plan Trust Fund, Arrowstreet Capital Limited Partnership, William Blair Investment Management LLC, Granahan Investment Management LLC, PEAK6 Investments LLC, and Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management .

How do I buy shares of InMode?

Shares of INMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InMode's stock price today?

One share of INMD stock can currently be purchased for approximately $23.35.

How much money does InMode make?

InMode has a market capitalization of $1.94 billion and generates $357.57 million in revenue each year. The healthcare company earns $164.97 million in net income (profit) each year or $1.9650 on an earnings per share basis.

How many employees does InMode have?

InMode employs 362 workers across the globe.

Does InMode have any subsidiaries?

The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..

When was InMode founded?

InMode was founded in 2008.

What is InMode's official website?

The official website for InMode is www.inmodemd.com.

How can I contact InMode?

InMode's mailing address is TAVOR BUILDING SHAAR YOKNEAM POB 533, YOKNEAM L3, 2069200. The healthcare company can be reached via phone at 972-4909-7470 or via email at [email protected].

This page was last updated on 5/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.